Aimz Investment Advisors Boosted Position in Teva Pharmaceutical Inds LTD (TEVA); As Omnicom Group (OMC) Market Valuation Declined, Chatham Capital Group Trimmed Holding

February 18, 2018 - By Darrin Black

Aimz Investment Advisors Llc increased its stake in Teva Pharmaceutical Inds Ltd (TEVA) by 73.41% based on its latest 2017Q3 regulatory filing with the SEC. Aimz Investment Advisors Llc bought 63,202 shares as the company’s stock declined 15.11% while stock markets rallied. The institutional investor held 149,292 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $2.63M, up from 86,090 at the end of the previous reported quarter. Aimz Investment Advisors Llc who had been investing in Teva Pharmaceutical Inds Ltd for a number of months, seems to be bullish on the $21.25B market cap company. The stock increased 0.43% or $0.09 during the last trading session, reaching $20.9. About 14.77M shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since February 18, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Chatham Capital Group Inc decreased its stake in Omnicom Group Inc (OMC) by 66.45% based on its latest 2017Q3 regulatory filing with the SEC. Chatham Capital Group Inc sold 74,005 shares as the company’s stock declined 2.32% while stock markets rallied. The institutional investor held 37,370 shares of the advertising company at the end of 2017Q3, valued at $2.77M, down from 111,375 at the end of the previous reported quarter. Chatham Capital Group Inc who had been investing in Omnicom Group Inc for a number of months, seems to be less bullish one the $18.15B market cap company. The stock increased 1.86% or $1.44 during the last trading session, reaching $78.72. About 4.27M shares traded or 56.96% up from the average. Omnicom Group Inc. (NYSE:OMC) has risen 1.15% since February 18, 2017 and is uptrending. It has underperformed by 15.55% the S&P500.

Investors sentiment increased to 1 in 2017 Q3. Its up 0.11, from 0.89 in 2017Q2. It increased, as 56 investors sold OMC shares while 213 reduced holdings. 65 funds opened positions while 203 raised stakes. 230.60 million shares or 2.33% more from 225.35 million shares in 2017Q2 were reported. Acadian Asset Mgmt reported 211,695 shares stake. Ameriprise reported 575,634 shares. Welch Forbes Limited Liability Corp has invested 0.47% of its portfolio in Omnicom Group Inc. (NYSE:OMC). 17,822 were accumulated by Kdi Capital Partners Ltd Limited Liability Company. Hamilton Point Inv Advsrs Ltd Limited Liability Company stated it has 21,300 shares. Moreover, Royal National Bank & Trust Of Canada has 0.01% invested in Omnicom Group Inc. (NYSE:OMC) for 291,601 shares. Gsa Cap Prtn Ltd Liability Partnership holds 0.02% of its portfolio in Omnicom Group Inc. (NYSE:OMC) for 4,187 shares. has 117 shares for 0% of their portfolio. First Citizens National Bank & reported 0.05% stake. State Common Retirement Fund invested in 583,468 shares. Sei Investments reported 0.01% stake. 3,249 were reported by Fayez Sarofim And Com. Sun Life Financial owns 5,380 shares. Barclays Public Ltd Liability Co owns 0.03% invested in Omnicom Group Inc. (NYSE:OMC) for 435,878 shares. Fmr Ltd Com reported 3.54 million shares.

Among 15 analysts covering Omnicom (NYSE:OMC), 4 have Buy rating, 1 Sell and 10 Hold. Therefore 27% are positive. Omnicom had 48 analyst reports since July 23, 2015 according to SRatingsIntel. Telsey Advisory Group maintained Omnicom Group Inc. (NYSE:OMC) on Wednesday, July 20 with “Market Perform” rating. The rating was downgraded by RBC Capital Markets on Friday, February 16 to “Hold”. The rating was maintained by RBC Capital Markets with “Buy” on Friday, July 21. Credit Suisse initiated the shares of OMC in report on Thursday, September 15 with “Neutral” rating. BMO Capital Markets maintained the shares of OMC in report on Thursday, July 13 with “Hold” rating. Jefferies maintained Omnicom Group Inc. (NYSE:OMC) rating on Monday, September 18. Jefferies has “Hold” rating and $82.0 target. The rating was maintained by RBC Capital Markets on Tuesday, October 17 with “Buy”. The firm earned “Neutral” rating on Friday, February 16 by Macquarie Research. The firm earned “Outperform” rating on Wednesday, March 8 by RBC Capital Markets. RBC Capital Markets maintained the stock with “Buy” rating in Tuesday, June 20 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts